Insight Clinical Trials is now enrolling for the Green Memory Study that will evaluate a naturally derived, investigational medication for mild to moderate Alzheimer’s disease (AD). This innovative study seeks to determine if re-balancing certain bacteria in the gut can make a difference in the progression of Alzheimer's. 

​

This investigational medication has been approved for use treating Alzheimer’s disease outside the US, and the Green Memory study is now being tested here. There is no cost to participate.

 

The investigational medication is a capsule taken by mouth and is designed to restore the natural balance of bacteria in the gut. Certain bacteria are thought to cause inflammation in the brain and nerves, possibly contributing to AD.

​

Who can take part?

We are looking for people who:

• Are between 50 and 85 years of age

• Have been diagnosed with mild to moderate AD. 

​​

Study participants must have a “study partner” who has known them for at least a year, knows them well, and is with them 3 or more days a week. The study partner will need to go with the participant to study visits.

Those who qualify may receive:

• Study-related care from local doctors at no cost

• Study medication at no cost

• Compensation for travel

​

The Green Memory study involves six visits to Insight Clinical Trials over a year of treatment, and four additional visits conducted over the phone. During the treatment period, 50% of participants will receive the investigational medication while 50% of participants will receive a placebo (an inactive medication). Every participant may be eligible receive the investigational medication for 26 weeks after completion of their initial year of study participation.

​